XML 11 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2018
Dec. 31, 2017
Current Assets:    
Cash and cash equivalents $ 11,187,000 $ 1,815,000
Available-for-sale marketable securities 13,959,000
Prepaid expenses and other current assets 507,000 422,000
Total current assets 25,653,000 2,237,000
Property and equipment, net 802,000 885,000
Restricted cash 171,000 225,000
Indefinite intangible asset 77,090,000
Goodwill 15,682,000
Total assets 119,398,000 3,347,000
Current Liabilities:    
Accounts payable 3,420,000 2,324,000
Collaboration and device development payable, net 2,576,000 4,418,000
Accrued expenses 6,465,000 4,134,000
Deferred revenue - current portion 198,000 884,000
Loan payable 7,974,000
Total current liabilities 20,633,000 11,760,000
Restructured debt liability - contingent milestone payments 15,000,000 15,000,000
Deferred revenue - non-current portion 407,000
Deferred tax liabilities 15,476,000
Other liabilities 175,000 100,000
Total liabilities 51,284,000 27,267,000
Stockholders' Equity:    
Preferred stock, $0.001 par value; 5,000,000 shares authorized; 0 shares and 2,701 shares issued and outstanding at December 31, 2018 and December 31, 2017, respectively
Common stock, $0.001 par value; 120,000,000 shares authorized at December 31, 2018 and December 31, 2017; 32,133,263 and 3,227,495 shares issued at December 31, 2018 and December 31, 2017, respectively; 32,133,189 shares and 3,227,421 shares outstanding at December 31, 2018 and December 31, 2017, respectively 32,000 3,000
Additional paid-in capital 728,783,000 616,245,000
Accumulated deficit (657,647,000) (637,114,000)
Treasury stock (at cost); 74 shares (3,054,000) (3,054,000)
Total stockholders' equity 68,114,000 (23,920,000)
Total liabilities & stockholders' equity $ 119,398,000 $ 3,347,000